John Maslowski
President & CEO, Forge Biologics, A Member of Ajinomoto Bio-Pharma Services
John Maslowski joined the leadership team as Chief Executive Officer and President of Forge Biologics, previously serving as the inaugural Chief Commercial Officer. He brings over 20 years of experience in pharmaceutical and biologics development, specializing in cell and gene therapy. Prior to Forge, he served as President & CEO of Castle Creek Biosciences and Fibrocell Science, leading Fibrocell through its acquisition in 2019.
Career
Mr. Maslowski has held leadership roles at Wyeth Pharmaceuticals, Merck & Co., Inc., and Teva Pharmaceuticals. He serves on the board of the Alliance for Regenerative Medicine and the advisory boards of Castle Creek Biosciences and Life Science Cares Philadelphia.
Education
Mr. Maslowski earned his B.S. in biology from Ursinus College and his M.S. in microbiology from Villanova University.